BioLineRx (BLRX) Long-Term Debt Repayments (2013 - 2026)
BioLineRx's Long-Term Debt Repayments came in at -$1.12 million for the quarter ended Jun 30, 2026, compared with -$1.12 million a year earlier.
Powered by 
Analysis
BioLineRx (BLRX) Long-Term Debt Repayments (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, BioLineRx reported Long-Term Debt Repayments of -$4.5 million; for the year ended Dec 31, 2025, it came in at -$4.5 million.
- Going back by year, Long-Term Debt Repayments was -$14.43 million in the year ended Dec 31, 2024, -$1.54 million in the year ended Dec 31, 2023, -$2.83 million in the year ended Dec 31, 2022 and -$3.38 million in the year ended Dec 31, 2021.
- The five-year range for quarterly Long-Term Debt Repayments is -$11.97 million (the quarter ended Dec 31, 2024) to -$49,000 (the quarter ended Mar 31, 2023).
- Business Quant data shows BLRX's Long-Term Debt Repayments at -$1.12 million (quarter ended Mar 31, 2026), -$1.14 million (quarter ended Dec 31, 2025) and -$1.12 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.00 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -2.45 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 17.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | BioLineRx | 6.14 Bn | 6.14 Bn | 235,000.00 | -1.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.12 Mn |
| Mar 31, 2026 | -1.12 Mn |
| Dec 31, 2025 | -1.14 Mn |
| Sep 30, 2025 | -1.12 Mn |
| Jun 30, 2025 | -1.12 Mn |
| Mar 31, 2025 | -1.12 Mn |
| Dec 31, 2024 | -11.97 Mn |
| Sep 30, 2024 | -914,000.00 |
| Jun 30, 2024 | -782,000.00 |
| Mar 31, 2024 | -765,000.00 |
| Dec 31, 2023 | -741,000.00 |
| Sep 30, 2023 | -619,000.00 |
| Jun 30, 2023 | -134,000.00 |
| Mar 31, 2023 | -49,000.00 |
| Sep 30, 2022 | -1.02 Mn |
| Jun 30, 2022 | -917,000.00 |
| Mar 31, 2022 | -895,000.00 |
| Dec 31, 2021 | -874,000.00 |
| Sep 30, 2021 | -854,000.00 |
| Jun 30, 2021 | -834,000.00 |
API Access
BioLineRx Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();